CLOSING AGREEMENTClosing Agreement • June 12th, 2023 • Bioxytran, Inc • Pharmaceutical preparations
This Closing Agreement (the “Agreement”), dated as of June 6, 2023 (the “Issue Date”), is entered into between Bioxytran, Inc. a Nevada corporation (the “Company”), and TRITON FUNDS LP, a Delaware limited partnership (the “Investor”).
AMENDMENT TO ENGAGEMENT LETTEREngagement Letter • June 12th, 2023 • Bioxytran, Inc • Pharmaceutical preparations
THIS AMENDMENT TO ENGAGEMENT LETTER (this “Amendment”) is dated May 8, 2023 and is made by and between BioXyTran Inc. (“BioXyTran”) has engaged WallachBeth Capital LLC (“WallachBeth” and, together with BioXyTran, the “Parties”).
